S100A9抑制和重定向蛋白89-230片段的粉样蛋白聚合
Mantas Ziaunys1, Darius Sulskis1, Kamile Mikalauskaite1
1Institute of Biotechnology, Life Sciences Center, Vilnius University, LT-10257, Vilnius, Lithuania.
Archives of biochemistry and biophysics
|July 8, 2024
概括
S100A9和蛋白之间的相互作用影响了粉样蛋白的形成. 特别是在纤维状形式的S100A9,它调节了蛋白聚合,这表明它在神经退行性疾病途径中发挥了作用.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 粉样纤维素与神经退行性疾病 (如阿尔茨海默氏症和帕金森症) 有关.
- 蛋白质交叉相互作用可以改变粉样蛋白聚合途径和聚合结构.
- 在神经退行症中S100A9和蛋白之间的相互作用尚未完全理解.
研究的目的:
- 为了研究S100A9和小鼠蛋白片段之间的体外交叉相互作用.
- 确定S100A9如何影响蛋白聚合通路和动力学.
- 探索S100A9在神经退行性疾病中的潜在治疗影响.
主要方法:
- 实验室聚合试验用于研究S100A9和小鼠蛋白 (PrP) 89-230片段之间的相互作用.
- 评估了纤维状和非聚合的S100A9对PrP聚合的影响.
- 特别研究了初级核化抑制.
主要成果:
- 纤维素S100A9显著调节了小鼠PrP 89-230碎片的聚合途径.
- 非聚合的S100A9在PrP聚合的初级核化上表现出显著的抑制作用.
- 这些发现表明S100A9在调节粉样蛋白形成中的复杂作用.
结论:
- 在纤维状和非聚合状态下,S100A9都会影响蛋白聚合.
- 这些发现支持S100A9在粉样蛋白聚合和神经退行性疾病的背景下发挥作用.
- 对S100A9机制的进一步研究可能会揭示对神经退行性疾病的治疗策略.
更多相关视频
09:43Purification and Refolding to Amyloid Fibrils of His6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli
Published on: December 19, 2015
14.2K
10:10Use of Two Dimensional Semi-denaturing Detergent Agarose Gel Electrophoresis to Confirm Size Heterogeneity of Amyloid or Amyloid-like Fibers
Published on: April 26, 2018
9.8K
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
